The Valley Desk

NCT00433381 · Interventional trial

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Overall registry status Completed

Phase 2

Conditions Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov